Aferian (LON: AFRN) is now securely into microcap territory with a market capitalisation of only £50 million. That's the sort of territory where we as wise investors or traders rightly fear to tread. Trade volumes are going to be low, spreads wide, this is the arena which is more akin to betting than stock trading, let alone investment.
However, it does depend upon how a company gets into microcap status. If it's a formerly much larger business - as with Aferian - that has fallen then perhaps there is something there that we'd like to have a look at. A large company at a low valuation is different from a small company at a small valuation after all.
Aferian share price from London Stock ExchangeThe specific problem seems to be that the customer base for the corporate product at Aferian simply isn't there. Or, as the company itself says, folk are delaying their purchases. Well, that happens of course but the question for us out here is whether we accept that description. For people delaying purchases can indeed be cashflow considerations on their part and so on. They can also delay because they're not particularly sold on the benefits of what is to be bought. Delays can be, that is, about cash, they can also be about not being very interested in the product.
Which this is matters rather a lot of course. On one side we've got what the company tells us today. On the other we've the fact that they said something very similar 6 months back. Aferian revenues were down because - well, because Aferian customers were delaying purchase decisions. There's that delay and then there's delay leading into actually fewer, rather than later, orders.
So that's one of the things we need to make our minds up about. Are we seeing here mere delay, in which case the business and thus the share price will recover? Or are we seeing weak sales just because, well, sales are weak?
The other thing to worry about is this line in the corporate release from Aferian:
The Company has already announced that it expects to report revenue and adjusted operating profit for the year ended 30 November 2022 in line with the trading update published on 8 December 2022.
The Company is in compliance with its banking covenants and is in discussions with its banks to ensure future covenant compliance. This will delay the announcement of the full year audited results for the year ended 30 November 2022. A further announcement will be made as and when practicable.
No, that's not good, not good at all. Delays in accounts are not a good sign, banks mithering about covenants isn't something we ever want to hear. A useful guide - only a guide of course - is that the next re-evaluation of Aferian is going to be when the results arrive along with the news that the banks are happy about those covenants. Or not, of course.



